| DNA Plasmid pUC19 |
pUC19 DNA is isolated from E.coli (dam+, dcm+) and purified by ultracentrifugation twice through a cesium chloride gradient in the presence of ethidium bromide. The molecule is a double-stranded circle, 2686 base pairs in length. GenBank/EMBL acce... |
50ug |
D3932-11 |
UNITED STATES BIOLOGICAL |
More Info
|
| UCB 35625 |
Potent CCR1 and CCR3 antagonist |
1 mg |
2757 |
TOCRIS BIOSCIENCE |
More Info
|
| UCB 35625 |
Potent CCR1 and CCR3 antagonist |
10 mg |
2757 |
TOCRIS BIOSCIENCE |
More Info
|
| c-Ha-ras-1 human pUCEJ6.6 |
n/a |
n/a |
n/a |
AMERICAN TYPE CULTURE COLLECTION |
More Info
|
| EZ4U-Cell Proliferation & Toxicity (EZ4U) Assay |
The EZ4U Assay is non-radioactive cell proliferation and cytotoxicity assay that is similar to the method designed to measure thymidine incorporation into cellular DNA. The EZ4U assay is performed in a 96-well plate and the color change (derived f... |
96 Wells |
04-BI-5000 |
ALPCO DIAGNOSTICS |
More Info
|
| Omi/HtrA2 Protease Inhibitor, Ucf-101 |
A cell-permeable furfurylidine-thiobarbitu ric acid compound that acts as a potent, specific, competitive, and reversible inhibitor of the pro-apoptotic, heat-inducible, mitochondrial serine protease Omi/HtrA2 (IC50 = 9.5 µM for His-Omi134-45... |
n/a |
496150 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| Protein Gene Product 9.5, Control Peptide (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
Control Peptide for P9102-70GSequence:ASSEDTL LKDAAKVCRPGP9.5/UCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Protein gene product (PGP9.5) is a neuron specific p... |
1mg |
P9102-70G1 |
UNITED STATES BIOLOGICAL |
More Info
|
| Protein Gene Product 9.5, Recombinant, Human (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
PGP9.5 1-223aaPGP9.5/UCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. PGP9.5 is a component of the ubiquitin system, which has a fundamental role in regulating va... |
100ug |
P9102-70H |
UNITED STATES BIOLOGICAL |
More Info
|
| Protein Gene Product 9.5, Recombinant, Human (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
PGP9.5/UCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Protein gene product (PGP9.5) is a neuron specific protein, structurally and immunologically distinct from... |
2ug |
P9102-72A |
UNITED STATES BIOLOGICAL |
More Info
|
| Protein Gene Product 9.5, Recombinant, Human (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
PGP9.5/UCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Protein gene product (PGP9.5) is a neuron specific protein, structurally and immunologically distinct from... |
50ul |
P9102-72 |
UNITED STATES BIOLOGICAL |
More Info
|
| Ubiquitin C-Terminal Hydrolase L3 (UCH-L3, UCH-30kD), Rabbit |
UCHs are a family of cysteine hydrolases that catalyze the hydrolysis of amides, esters, and thioesters from the C-Terminus of ubiquitin (Ub). UCH-L3 is a member of the low molecular weight UCHs that process ubiquitin precursors and ubiquitinated ... |
10ug |
U1005-01B |
UNITED STATES BIOLOGICAL |
More Info
|
| Ubiquitin C-Terminal Hydrolase L3 (UCH-L3, UCH-30kD), Recombinant, Human |
UCHs are a family of cysteine hydrolases that catalyze the hydrolysis of amides, esters, and thioesters from the C-terminus of ubiquitin (Ub). UCH-L3 is a member of the low molecular weight UCHs involved in the hydrolysis of small C-terminal deriv... |
25ug |
U1005-01C |
UNITED STATES BIOLOGICAL |
More Info
|
| Ubiquitin C-terminal hydrolase L1 (UCH-L1) |
Specific Activity: >1000 pmol/min/ug. Determined at 25?C with 1 uM ubiquitin-AMC as substrate and UCH-L1 at 20 pM (0.54 ng/mL). |
50 ug |
14-855 |
MILLIPORE |
More Info
|
| Ubiquitin C-terminal hydrolase L3 (UCH-L3) |
Specific Activity: >1000 pmol/min/ug. Determined at 25?C with 1 uM ubiquitin-AMC as substrate and UCH-L3 at 20 pM (0.58 ng/mL). |
50 ug |
14-856 |
MILLIPORE |
More Info
|
| UCH-L1 Inhibitor |
An isatin O-acyl oxime compound that acts as a potent, reversible, competitive, and active site-directed inhibitor of UCH-L1 (Ki = 0.40 µM; IC50 = 0.88 µM) with ~28-fold greater selectivity over UCH-L3 (Cat. No. 662090). Shown to incre... |
n/a |
662086 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| UCH-L3 Inhibitor |
A 1,3-indanedione compound that acts as a selective and potent inhibitor of UCH-L3 (IC50 = 0.6 µM) with ~125-fold greater selectivity over UCH-L1 (IC50 = 75 µM). |
n/a |
662089 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| UCH-L4 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154884 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L5 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-76797 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L5 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-76798 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L1 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-42304 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L1 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-42305 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L3 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-42306 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCH-L3 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-42307 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCK2 Recombinant Protein, aa. 1-261 |
Purity: 95%. Accession #: NP_036606. GI #: 18699734. The protein encoded by this gene catalyzes the phosphorylation of uridine monophosphate to uridine diphosphate. This is the first step in the production of the pyrimidine nucleoside triphosphate... |
0.05 mg |
XW-RP3282 |
PROSCI INC. |
More Info
|
| UCK2 |
The RP-39381 UCK2 protein is a full length bacterially expressed recombinant protein.RP-39381 is suitable for use as a control in ELISA and Western blot applications.The RP-39381 amino acid sequence corresponds to the NCBI accession number NP_0366... |
10 ug |
RP-39381 |
ABR - AFFINITY BIOREAGENTS INC. |
More Info
|
| UCK2, Human Recombinant with His Tag |
Entrez Gene ID: 7371 |
50 µg |
CRU100 |
CELL SCIENCES INC. |
More Info
|
| UCK1 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154885 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCK2 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-88781 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCK1 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-92649 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCK2 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-106664 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCKL1 siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154886 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCKL1 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-76799 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCKL1OS siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-76800 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCKL1 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-106665 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| UCL 1684 |
Highly potent blocker of SKCa |
5 mg |
1310 |
TOCRIS BIOSCIENCE |
More Info
|
| UCL 2077 |
Slow afterhyperpolarisation (sAHP) channel blocker |
10 mg |
2661 |
TOCRIS BIOSCIENCE |
More Info
|
| UCL 2077 |
Slow afterhyperpolarisation (sAHP) channel blocker |
50 mg |
2661 |
TOCRIS BIOSCIENCE |
More Info
|
| UCM707 |
n/a |
n/a |
n/a |
CAYMAN CHEMICAL CO. |
More Info
|
| UCM 707 |
Potent anandamide transport inhibitor |
10 mg |
1966 |
TOCRIS BIOSCIENCE |
More Info
|
| UCM 707 |
Potent anandamide transport inhibitor |
50 mg |
1966 |
TOCRIS BIOSCIENCE |
More Info
|
| Ucma siRNA (mouse) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-154887 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|
| Antibiotic UCN-01 (7-Hydroxystaurosporine, UCN-01) |
Isolated from Streptomyces sp., Antibiotic UCN-01 inhibits protein kinase C (PKC) and cyclin-dependant kinase 2 (CDK2) resulting in accumulation of cells in the G1 phase and induction of apoptosis. UCN-01 also enhances the cytotoxicity of other an... |
1mg |
A2297-39 |
UNITED STATES BIOLOGICAL |
More Info
|
| Antibiotic UCN-02 (UCN 02) |
UCN-02 is isolated as a minor co-metabolite of high producing staurosporine strains of selected actinomycetes. Although less selective than its isomer UCN-01, UCN-02 exhibits comparable activity and probably acts by similar mechanisms. Purity: >95... |
1mg |
A2297-39A |
UNITED STATES BIOLOGICAL |
More Info
|
| Calphostin C (Antibiotic UCN-1028 C, UCN 1028 C) |
Calphostin C is a perylenequinione isolated from the fungus, Cladosporium cladosporioides. It is a potent and specific inhibitor of protein kinase C with inhibition being light dependent. Also shown to inhibit cell proliferation and induce apoptos... |
100ug |
C1035-38 |
UNITED STATES BIOLOGICAL |
More Info
|
| UCN-01 |
A cell-permeable Staurosporine (Cat. No. 569397) derived anticancer agent that reversibly and ATP-competitively inhibits several protein kinases (IC50 = 29 nM, 34 nM, 30 nM, 590 nM and 530 nM for PKCα, PKCβ, PKCγ, PKCδ and P... |
n/a |
539644 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| UCN-02 |
A cell-permeable ATP-competitive PKC inhibitor that exhibits decreased potency and selectivity towards calcium-dependent isoforms (IC50 = 0.53, 0.7, 0.39, 2.83, and 1.23 µM for PKCα, PKCβ, PKCγ, PKCδ, and PKCε,... |
n/a |
539645 |
CALBIOCHEM/EMD BIOSCIENCES |
More Info
|
| UCP3 peptide |
This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and mouse UCP 3, catalog GT23477. Using a solution of peptide of equal volume and concentration to the corresponding ant... |
50 ug |
GTX24994 |
GENETEX INC. |
More Info
|
| Recombinant Human UCP2 (partial) |
n/a |
100 µg |
565801 |
BIOLEGEND |
More Info
|
| Recombinant Human UCP4 |
n/a |
100 µg |
565901 |
BIOLEGEND |
More Info
|
| UCP4 siRNA (human) |
Target specific 19-25 nt siRNAs designed to knock down expression of specific gene of interest. Each vial contains 3 nmol of lyophilized siRNA and is sufficient for 50 - 100 transfections. |
10 µM |
sc-36775 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info
|